In Reply to "Letter Regarding 'Dose-Response of Tenapanor in Patients With Hyperphosphatemia Undergoing Hemodialysis in Japan-A Phase 2 Randomized Trial'".

ABSTRACT:

SUBMITTER: Inaba M 

PROVIDER: S-EPMC9263242 | biostudies-literature | 2022 Jul

REPOSITORIES: biostudies-literature